High seroprevalence of anti-Mycoplasma fermentans antibodies in patients with malignant aphthosis [2]

Journal of Investigative Dermatology

Volumn 121, Issue 1, 2003, Pages 211-212

  Zouboulis, Christos C ^a   Turnbull, Julia R ^a   Mühlradt, Peter F ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; LIPOPROTEIN;

ADULT; APHTHOUS STOMATITIS; AUTOIMMUNITY; BEHCET DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INFLAMMATION; LETTER; MACROPHAGE ACTIVATION; MALE; MYCOPLASMA HOMINIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; SEROPREVALENCE;

EID: 0041342081     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2003.12303.x     Document Type: Letter

References (10)

1. Alpsoy E, Kodelja V, Goerdt S, Orfanos CE, Zouboulis ChC: Serum of patients with Behçet's disease induces classical (pro-inflammatory) activation of human macrophages in vitro. Dermatology 206:225-232, 2003
2. Calcutt MJ, Kim MF, Karpas AB, Mühlradt PF, Wise KS: Differential post-translational processing confers intraspecies variation of a major surface lipoprotein and macrophage-activating lipopeptide (MALP-2) of Mycoplasma fermentans. Infect Immun 67:760-771, 1999
3. Davis KL, Wise KS: Site-specific proteolysis of the MALP-404 lipoprotein determines the release of a soluble selective lipoprotein-associated motif-containing fragment and alteration of the surface phenotype of Mycoplasma fermentans. Infect Immun 70:1129-1135, 2002
4. Falk K, Rötzschke O, Takiguchi M, Gnau V, Stefanovic S, Jung G, Rammensee H-G: Peptide motifs of HLA-B51, -B52 and -B78 molecules, and implications for Behçet's disease. Int Immunol 7:223-228, 1995
5. International Study Group for Behçet's Disease: Criteria for diagnosis of Behçet's disease. Lancet 335:1078-1080, 1990
6. Sakane T, Takeno M, Suzuki N, Inaba G: Behçet's disease. N Engl J Med 341:1284-1291, 1999
7. Schaeverbeke T, Gilroy CB, Bébéar C, Dehais J, Taylor-Robinson D: Mycoplasma fermentans in joints of patients with rheumatic arthritis and other joint disorders. Lancet 347:1418, 1996
8. Zouboulis ChC: Epidemiology of Adamantiades-Behçet's disease. Ann Med Intern 150:488-498, 1999
9. Zouboulis ChC, May T: Pathogenesis of Adamantiades-Behçet's disease. J Med Microbiol Immunol, in press
10. Zouboulis ChC, Katsantonis J, Ketteler R, et al: Adamantiades-Behçet's disease: Interleukin-8 is increased in serum of patients with active oral and neurological manifestations and is secreted by small vessel endothelial cells. Arch Dermatol Res 292:279-284, 2000